SeaStar Medical is trading 12.3% down at $3.11, continuing its decline after the October 5 warrant deal raised potential dilution concerns. - The company agreed to raise about $3.3 million by repricing warrants for 854,002 shares and issuing new warrants for up to 1,708,004 shares. - No separate October 6 company explanation surfaced in the search; broader markets are modestly higher. - The CMO is scheduled to present at a pediatric therapy conference, but reporting does not link it to the share move.